To search for the signaling pathway critical for tumor invasion, we examined the eects of dominant negative ras (S17N ras) expression on the activation of matrix metalloproteinase-2 (MMP-2) in src-transformed 3Y1, SR3Y1, under the control of conditionally inducible promoter. In SR3Y1 clones transfected with S17N ras, augmented secretion and proteolytic activation of MMP-2 were dramatically suppressed by S17N Ras expression, while tyrosine phosphorylation of cellular proteins was not suppressed. We found that invasiveness of SR3Y1 cells assayed by the modi®ed Boyden Chamber method was strongly suppressed by S17N Ras expression. In contrast, cell morphology reverted partially and glucose uptake remained unchanged by S17N Ras expression. In addition, treatment of SR3Y1 with manumycin A, a potent inhibitor of Ras farnesyltransferase, strongly suppressed both augmented secretion and proteolytic activation of MMP-2. Contrary, treatment of SR3Y1 with wortmannin or TPA showed no clear eect on MMP-2 activation. Thus, these results strongly suggest that Ras-signaling, but neither P13 kinase-nor protein kinase C-signalings, plays a critical role in activation of MMP-2 and, subsequently, in the invasiveness of srctransformed cells.
Introduction
Destruction of extracellular matrix is the critical event for tumor invasion and metastasis. A group of neutral proteinases, the matrix metalloproteinase (MMPs), appears to catalyze this reaction (Liotta, 1986) . MMPs such as MMP-2 and MMP9 (Matrisian, 1990; Woessner, 1991) are secreted from the cells as inactive zymogens, and activated by proteolytic cleavage (Stetler-Stevenson et al., 1989) . A membrane-type MMP, MT1-MMP catalyzes activation of MMP-2 (Sato et al., 1994) . In human cancer tissues, increased secretion and proteolytic activation of MMPs showed good correlation with tumor metastasis (Kataoka et al., 1996) . Evidence accumulated, however, suggests that MMPs including MMP-2, MMP-9 and stromelysin-3 in tumor tissues are secreted from the stromal ®broblastic cells (Pyke et al., 1992; Ohtani et al., 1995; Okada et al., 1995) . Thus, in tumor tissues where tumor cell invasion is observed, secretion and proteolytic activation of MMPs appear to be activated in the interstitial ®broblasts.
Despite its importance, however, the mechanism on how activation of MMPs is regulated remains largely unclear. To study the signaling pathway critical for MMP activation in ®broblasts, we examined their activities in cells transformed with Rous Sarcoma virus (RSV), as a model . The oncogene product of Rous sarcoma virus (RSV), p60
v-src , is a membrane-bound tyrosine protein kinase (Collet and Erikson, 1978; Levinson et al., 1978) associated with cytoskeletal structures (Burr et al., 1980; Hamaguchi and Hanafusa, 1987) . We found that augmented secretion and proteolytic activation of MMP-2 showed close correlation with transforming activity of v-src . Other oncogene products, Yes, Fps, erbB and Crk, also stimulated the secretion and proteolytic activation of MMP-2 , suggesting the presence of signaling pathway critical for MMP-2 activation.
Ras-dependent signaling in v-src-transformed cells has drawn attention by its role. Microinjection of a neutralizing antibody against Ras suppressed transformation of v-src-transformed cells (Smith et al., 1986) . Expression of S17N Ras, a mutant Ras with Asn substituted for Ser at position 17 of H-ras yields a dominant inhibitory eect on endogenous Ras, resulted in inhibition of cell growth and morphological change of v-src-transformed cells (Feig and Cooper, 1988) . Similarly, expression of p120 GAP , a negative regulator of Ras, showed suppressive eects on transformation by vsrc (DeClue et al., 1991; Nori et al., 1991) . However, Aftab et al. (1997) reported that dominant negative Ras could not completely suppress the transformation of cells by v-src, suggesting that Ras signaling alone is not sucient. Recently, activation of signal transducers and activators of transcription (Stat) 3, a Ras-independent signaling, was found to be involved in cell transformation by v-src (Yu et al., 1995; Cao et al., 1996; Turkson et al., 1998; Bromberg et al., 1998) . Together with these ®ndings, v-src is also known to activate other signalings, phosphoinositide 3-kinase (PI3-kinase) (Fukui and Hanafusa, 1989) and protein kinase C (Zang et al., 1995) . Oncogene of the avian sarcoma virus 16 isolated by P Vogt encodes the catalytic subunit of PI3-kinase (Chang et al., 1997) , suggesting that PI3-kinase signaling is critical for cell transformation. Thus, several independent signaling pathways may be required for the complete cell transformation by v-src. All these studies, however, focused only on cell growth and morphological change. It is not yet clear whether all these signaling pathways are required for MMP-2 activation, or if there are any critical ones.
To examine the role of Ras-dependent signaling in MMP-2 activation, we established src-transformed cell lines in which dominant negative Ras is conditionally expressed under the control of mouse mammary tumor virus (MMTV) promoter/enhancer. Here we show evidence that Ras signaling is critical for the activation of MMP-2 in src-transformed cells. In addition, we show that treatment of SR3Y1 cells with manumycin A, a potent inhibitor of Ras farnesyltransferase, has suppressive eect on MMP-2 secretion, whereas wortmannin and TPA have no eect.
Results
Establishment of S17N ras-transfected SR3Y1 clones and eect of S17N Ras expression on p60 v-src A rat cell line, 3Y1 and 3Y1 transformed with RSV, SR3Y1 were used throughout the study. SR3Y1 was transfected with pMAM2-BSD vector alone or S17N ras ligated into pMAM2-BSD (Thant et al., 1997) . Blasticidin-resistant clones overexpressing Ras by dexamethasone-treatment were selected by immunoblotting with anti-pan Ras. Figure 1 showed results with two representative clones. By treatment with dexamethasone, S17N ras-transfected clones expressed higher levels of Ras, while control vector-transfected clone did not. In contrast, dexamethasone did not aect on p60 v-src expression in these cells (Figure 1a , lower panel). Guanine nucleotides bound to Ras in these cells were analysed by thin-layer chromatography. By treatment with dexamethasone, GTP bound Ras was dramatically reduced in S17N ras-transfected clones but not in vector-transfected clone and in parental SR3Y1 (Figure 1b) .
We examined the eects of S17N Ras on tyrosine phosphorylation of cellular proteins and p60 v-src kinase activity ( Figure 2 ). Neither tyrosine phosphorylation nor p60
v-src kinase activities were suppressed by S17N Ras expression.
MMP-2 activity in S17N ras-transfected SR3Y1
MMP-2 activities in the conditioned media of these cloned cells were examined by zymography with gelatin embedded gels. Protein concentrations of conditioned Figure 1 Expression of S17N Ras and its eect on GTP loading onto Ras in transfected cells. (a) 3Y1, H-ras-transfected 3Y1, SR3Y1, vector-transfected SR3Y1 and S17N ras-transfected SR3Y1 were incubated in the presence (+) or absence (7) of dexamethasone. Cells were collected and examined by immunoblotting with anti-pan Ras antibody or anti-Src antibody. (b) Cells were permeabilized with streptolysin O and labeled with a-32 P-GTP and solubilized. Ras was immunoprecipitated from equal amounts of protein extract and nucleotides bound to Ras were eluted and analysed by TLC. Relative ratio (%) of Ras-GTP to RasGDP+Ras-GTP was calculated based on the densitometry analysis media were similar levels and 50 ml of conditioned media were used for the assay. As previously reported , 3Y1 secreted small amount of MMP-2 only in a zymogen form of 68 kDa. In contrast, SR-3Y1 secreted MMP-2 both in a zymogen form and proteolytically activated form of 63 kDa ( Figure 3a ). In addition, relative activity of zymogen form MMP-2 secreted from SR3Y1 was strongly activated. H-ras-transformed 3Y1 had also elevated secretion and proteolytic activation of MMP-2 as previously reported (Collier et al., 1988) . Similarly, without treatment of dexamethasone, S17N rastransfected SR3Y1 clones had augmented secretion and proteolytic activation of MMP-2 to the level similar to parental SR3Y1. In contrast, S17N Ras expression in S17N ras-transfected SR3Y1 by treatment with dexamethasone resulted in drastic suppression of secretion and proteolytic activation of MMP-2. On the other hand, dexamethasone-treatment had no eect on MMP-2 secretion in vector-transfected SR3Y1.
The amounts of MMP-2 secreted from these cells were further examined by immunoblotting with anti-MMP-2 (Figure 3b ). It should be noted that anti-MMP-2 antibody could recognize both the zymogen and cleaved forms of MMP-2 when concentrated media were used, but detected only the zymogen form Figure 3 Eect of S17N Ras expression on the secretion of MMP-2. (a) Conditioned media from 3Y1, H-ras-transformed 3Y1, SR3Y1, vector-transfected 3Y1 and S17Nras-transfected SR3Y1 incubated with (+) or without (7) dexamethasone were collected and subjected to gelatin zymography as described in Materials and methods. Arrow indicates 68 kDa zymogen form of MMP-2 and arrow head indicates its 63 kDa active form. (b) Amounts of MMP-2 secreted in conditioned medium were examined by immunoblotting with anti-MMP-2 when conditioned media were directly used . These results were consistent with those of zymography.
Eect of S17N Ras on the production of MMP-2 and MT1-MMP We next examined production of MMP-2 in cells by immunoblotting (Figure 4a ). Transformation by v-src clearly up-regulated the production of MMP-2. We found, however, expression of S17N Ras did not decrease the steady state level of MMP-2 in cells, in contrast to those in the conditioned media. Expression of MT1-MMP in these cell lines was also examined by immunoblotting with anti-MT1-MMP antibody. We found that 3Y1 expressed substantial amount of MT1-MMP even though MMP-2 was not activated ( Figure  4b ). However, transformation by v-src and by H-ras upregulated the expression of MT1-MMP. In contrast, dexamethasone treatment did not suppress the MT1-MMP expression in S17N ras-transfected SR3Y1, while activation of MMP-2 was blocked. These results suggest that elevation of MMP-2 secretion by Ras signaling is controlled mainly at the level of secretion, and regulation of MT1-MMP production in v-srctransformed 3Y1 may dier, at least in part, from those of MMP-2.
Eect of S17N Ras expression on invasiveness of S17N ras-transfected SR3Y1
Eect of S17N Ras expression on the invasiveness of cells was assayed by the modi®ed Boyden Chamber method as described in Materials and methods. Cells were loaded on the upper chambers, and cells penetrated the membranes were ®xed, stained and counted (Figure 5b ). While 3Y1 showed almost no invasive activity, SR3Y1, vector-transfected SR3Y1 were able to penetrate through the membranes. In contrast, invasiveness of S17N ras-transfected SR3Y1 was strongly suppressed by treatment with dexamethasone, while it showed invasiveness to the level similar to SR3Y1 without dexamethasone treatment. We found that chemotaxis of S17N ras-transfected SR3Y1 clones, assayed with the chambers without the reconstituted basement membrane, was not perturbed by S17N Ras expression (Figure 5a ). These results suggest that Ras-dependent activation of MMP-2 plays an important role in the invasiveness of SR3Y1.
Eect of S17N Ras expression on cell morphology, growth and glucose uptake Cell transformation by p60 v-src is highly complexed process that arises pleiotropic eects on cells (Hanafusa, 1977) . We, therefore, examined the eect of S17N Ras expression on cell morphology, growth and glucose uptake. Cells were ®xed and stained with rhodamine-conjugated phalloidin to observe stress ®ber formation ( Figure 6 ). Treatment of vector-transfected SR3Y1 with dexamethasone had no clear eect on the morphology. In contrast, morphology of S17N rastransfected SR3Y1 clones became¯attened and showed weak recovery of stress ®ber by treatment with dexamethasone. Figure 4 Eect of S17N Ras expression on the production of MMP-2 and MT1-MMP in S17N ras-transfected SR3Y1. (a) Cell lysates of 3Y1, H-ras-transformed 3Y1, SR3Y1, vector-transfected 3Y1 and S17Nras-transfected SR3Y1 incubated with (+) or without (7) dexamethasone were collected and subjected to immunoblotting with antibody against MMP-2. (b) Steady-state levels of MT1-MMP in same cell lysates were examined by immunoblotting with monoclonal anti-MT1-MMP antibody v-Src activates MMP-2 via Ras pathway AA Thant et al Figure 6 Morphology and stress ®ber formation in S17Nras-transfected SR3Y1. SR3Y1 (a), 3Y1 (b), SR3Y1 transfected with vector alone (c, d) and S17N ras-transfected SR3Y1 clones, C1 (e, f), C2 (g, h) were ®xed. Transfected clones were cultured in the absence (c, e and g) or presence of dexamethasone (d, f and h). F-actin was visualized with rhodamine-conjugated phalloidin staining Figure 5 In vitro chemotaxis and invasiveness of S17N ras-transfected SR3Y1. Invasion assay was carried out as described in Materials and methods. 3Y1, SR3Y1 and S17N ras-transfected SR3Y1 clones were seeded onto an uncoated ®lter (a) or onto reconstituted basement membrane ®lter (b) to determine the activities of chemotaxis or invasiveness, respectively. After 16 h of incubation, cells invaded the lower surface of the ®lters were ®xed, stained and counted. The results were average values of three independent experiments v-Src activates MMP-2 via Ras pathway AA Thant et al
Eect of S17N Ras expression on cell growth was examined by MTT assay (Figure 7a ). SR3Y1 showed clearly higher rate of cell growth compared with that of 3Y1. Vector-transfected SR3Y1 showed similar high growth rate, and dexamethasone-treatment had no eect on its growth. S17N ras-transfected SR3Y1 clones without dexamethasone treatment showed high growth rates to the levels similar to that of SR3Y1. In contrast, S17N ras-transfected clones showed slower growth rate under the treatment with dexamethasone, although it was higher than that of 3Y1.
We next examined the eect of S17N Ras expression on the glucose-uptake of cells (Figure 7b ). SR3Y1 had around 1.7-fold higher level of glucose-uptake compared with 3Y1 as previously reported (Hatanaka and Hanafusa, 1970) . Vector-transfected SR3Y1 had similar levels of elevated glucose-uptake and dexamethasone-treatment had no eect on the rate. S17N ras-transfected SR3Y1 clones showed high glucoseuptake rates compared to that of 3Y1, and expression of S17N Ras in these clones showed no eect on elevated glucose-uptake. Thus, glucose-uptake rate of these clones did not show clear correlation with their morphological change nor MMP-2 activation.
Eect of manumycin A, TPA and wortmannin on MMP-2 activation
To con®rm the role of Ras-signaling in MMP-2 activation, we next examined the eect of manumycin A, a potent inhibitor of Ras farnesyltransferase (Tamanoi, 1993) , on SR3Y1. 3Y1 and SR3Y1 were pretreated with indicated doses of manumycin A as described in Materials and methods, and MMP-2 activities in conditioned media were assayed by zymography (Figure 8a,b) . We found that manumycin A strongly inhibited the secretion of MMP-2 both in SR3Y1 and 3Y1. In contrast to MMP-2, we found that MMP-9 was relatively resistant to manumycin Atreatment, suggesting that inhibition of MMP-2 activation by manumycin A is a speci®c eect rather than toxic and nonselective one. In contrast to manumycin A, neither high dose of TPA (Figure 8c ) for PKC inhibition, nor wortmannin (Figure 8d ) for PI3 kinase inhibition could suppress the secretion of MMP-2 in SR3Y1. These results suggest that both PKC and PI3 kinase are not essential for the activation of MMP-2 in SR3Y1.
Discussion
Elevation of MMPs activity in malignant tumor cells and cells transformed with various oncogenic agents has been widely observed (Liotta, 1986; Mullins and Rohrlich, 1983) . However, signaling pathway critical for the activation of MMPs remains largely unclear. In this report, we showed direct evidence that Rasdependent signaling is required for the activation of MMP-2 secretion in v-src-transformed cells by use of S17N ras.
Isolation of avian sarcoma virus 16 that encodes an oncogene consisted of the catalytic subunit of PI3 kinase (Chang et al., 1997) clearly demonstrate that PI3 kinase signaling can play a critical role in cell Figure 7 Cell viabilities and glucose-uptake rates of S17N ras-transfected SR3Y1. (a) Viability of 3Y1, H-ras-transformed 3Y1, SR3Y1, vector-transfected 3Y1 and S17Nras-transfected SR3Y1 incubated in the presence (+) or absence (7) of dexamethasone was measured by MTT assay. (b) The rate of glucose-uptake of these cells was assayed as described in Materials and methods v-Src activates MMP-2 via Ras pathway AA Thant et al transformation. However, treatment of SR3Y1 with wortmannin, a potent inhibitor of PI3 kinase, did not show inhibitory eect on MMP-2 secretion in SR3Y1, suggesting that PI3 kinase pathway is dispensible for the activation of MMP-2 secretion by v-Src. In this report, we showed that S17N Ras selectively suppressed the secretion, but not the production, of MMP-2. It is not clear whether production of S17N Ras in our system is not sucient for the clear suppression of MMP-2 production. However, experiment with manumycin A, a potent and speci®c inhibitor for Ras farnesyltransferase (Tamanoi, 1993) , con®rmed the observation with S17N Ras. Our results indicate that signaling pathway critical for MMP-2 secretion may dier in part from those of enhanced MMP-2 production. In addition to MMP-2 production, MT1-MMP production was not blocked by S17N Ras expression. These results may suggest that augmented secretion of MMP-2 is required in addition to the enhanced production of MT1-MMP for the ecient proteolytic activation of MMP-2.
By in vitro invasion assay with reconstituted basement membrane, we found that inhibition of MMP-2 activation by S17N Ras resulted in suppression of the invasiveness of SR3Y1. In the absence of dexamethasone, S17N ras-transfected clones had rounded cell morphology, high growth rate, elevated glucose-uptake and high invasive activities. When S17N Ras was expressed by treatment with dexamethasone, invasiveness of these clones was dramatically suppressed, while chemotactic activities of these clones were not suppressed. These results suggest that activation of MMP-2 secretion via Ras-signaling is required, at least in part, for the invasiveness of srctransformed 3Y1. In contrast to MMP-2 secretion, high glucose-uptake rate of S17N ras-transfected clones was not suppressed by dexamethasone treatment. It is likely that signaling pathway critical for elevated glucose-uptake may dier from that of MMP-2 secretion and invasiveness. Similarly, recovery of the stress ®ber formation in S17N ras-transfected clones was not complete, although cell morphology becamē attened. It is not clear whether expression of S17N Ras by MMTV promoter was not sucient for the recovery of stress ®ber or other signaling pathway is required for the complete recovery of stress ®ber. At any rate, these results suggest that activation of MMP-2 secretion is more sensitive than elevated glucoseuptake and stress ®ber formation to S17N Ras expression.
In this study, we showed, for the ®rst time, that Rassignaling is critical for the invasiveness of v-srctransformed cells. However, increasing evidence suggests that Ras signaling is not simple but has Figure 8 Eects of manumycin, TPA or wortmannin on secretion of MMP-2 in SR3Y1. 3Y1 (a) and SR3Y1 (b ± d) were treated with indicated doses of manumycin A (a, b), TPA (c) or wortmannin (d) as described in Materials and methods. Conditioned media were collected and subjected to gelatin zymography. Arrows indicate zymogen forms of MMP-2 and MMP-9, and arrow head indicates active form of MMP-2. Relative ratio of Ras-GTP to Ras-GDP in SR3Y1 treated or untreated with manumycin was analysed by TLC complexity in its down-stream eectors (Campbell et al., 1998) . Further study to idendify the down-stream eector critical for the activation of MMP-2 secretion is an important problem to be clari®ed.
Materials and methods

Transfection of SR 3Y1 cells
Rat ®broblast cell line, 3Y1, and SR-RSV-transformed 3Y1 (SR-3Y1) were maintained as described previously (Hamaguchi and Hanafusa, 1987; Kawai, 1980) . Transfection of S17N ras ligated into pMAM2BSD expression vector was performed as previously reported (Thant et al., 1997) . Blasticidin-resistant clones expressing S17N Ras in the presence of dexamethasone were selected as previously described (Thant et al., 1997) .
Uptake of GTP onto Ras
Uptake of GTP onto Ras were determined as described (Klein and Schneider, 1997) . Cells were harvested in permeabilizing buer (150 mM KCl, 37.5 mM NaCl, 6.25 mM MgCl 2 , 0.8 mM CaCl 2 , 1 mM EGTA, 1.25 mM ATP, 12.5 mM PIPES pH 7.4, streptolysin O 0.4 U/ml). Cells were mixed with 10 mCi of [a-32 P]GTP, incubated at 378C for 10 min, suspended in Lysis buer (1% Triton X-100, 20 mM Tris-HCl pH 7.5, 10 mM MgCl 2 150 mM NaCl, 1 mM PMSF, 1 mM Na 3 VO 4 , 50 mM NaF, 10 mg/ml of leupeptin, 10 mg/ml of aprotinin) and immunoprecipitated with Ras-speci®c antibody. Nucleotides bound to Ras were eluted in 20 mM Tris-HCl pH 7.5, 20 mM EDTA, 2% SDS at 658C for 5 min, spotted onto polyethyleneimine cellulose, separated by ascending thin-layer chromatography at pH 3.4 and autoradiographed.
